How targeted therapy affects thinking and memory in blood cancer
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study examines whether a new type of cancer medication affects thinking, memory, and focus in people with chronic myeloid leukemia (CML) or chronic lymphocytic leukemia (CLL). Researchers will compare people starting this medication with healthy volunteers to understand any changes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have CML or CLL and are starting a targeted therapy medication (called a TKI) for the first time, or started it within the last month
- You are at least 18 years old and able to speak and read English
- You have not had other cancer treatments like chemotherapy, radiation, or immunotherapy in the past 5 years (with some exceptions)
- You have not had a stroke in the past year or brain tumor/brain radiation ever
- You do not have dementia, severe nerve disease, or a psychiatric hospitalization in the past year
- You are not pregnant and not colorblind
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether chemotherapy for blood cancers like leukemia and lymphoma can affect thinking, memory, or concentration. It compares patients to a close family member or friend to see if any changes are related to the treatment.
This study looks at whether immunotherapies for blood cancers affect thinking and memory. If you are receiving this treatment, researchers will track your cognitive function over time to better understand and manage any changes.
This study looks at how a special type of immunotherapy called CAR-T therapy might affect your thinking skills, memory, and ability to focus. By checking on patients early and often, the team hopes to find simple ways to detect and manage these side effects sooner.
This study tests whether special brain exercises can help protect thinking and memory skills during CAR-T cell therapy—a newer cancer treatment for certain blood cancers. Researchers want to see if training your brain during treatment reduces side effects on memory and mental function.
This study looks at memory and thinking problems in older adults receiving chemotherapy for blood cancers. By participating, you help doctors understand how these treatments affect the mind.
This study looks at how CAR-T cell therapy affects memory and thinking skills in adults with certain types of lymphoma. The results may help doctors understand and support patients better during treatment.
Hear when a new Chronic Myeloid Leukemia, BCR-ABL1 Positive trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.